These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26599915)

  • 21. Cardiac Fgf-16 Expression Supports Cardiomyocyte Survival and Increases Resistance to Doxorubicin Cytotoxicity.
    Wang J; Xiang B; Dolinsky VW; Kardami E; Cattini PA
    DNA Cell Biol; 2018 Nov; 37(11):866-877. PubMed ID: 30230915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taurine Has Potential Protective Effects against the Chronic Cardiotoxicity Induced by Doxorubicin in Mice.
    Zhang H; Guo J; Cui S; Zhou Y
    Biol Pharm Bull; 2021; 44(11):1732-1737. PubMed ID: 34719649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes.
    Han XZ; Gao S; Cheng YN; Sun YZ; Liu W; Tang LL; Ren DM
    Biosci Trends; 2012 Feb; 6(1):19-25. PubMed ID: 22426099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases.
    Kang YJ; Zhou ZX; Wang GW; Buridi A; Klein JB
    J Biol Chem; 2000 May; 275(18):13690-8. PubMed ID: 10788488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metallothionein inhibited DOX-induced cardiac apoptosis in mice].
    Shuai Y; Guo J; Peng SQ; Zhang LS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):620-3. PubMed ID: 17718425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-mitogenic FGF2 protects cardiomyocytes from acute doxorubicin-induced toxicity independently of the protein kinase CK2/heme oxygenase-1 pathway.
    Koleini N; Nickel BE; Edel AL; Fandrich RR; Ravandi A; Kardami E
    Cell Tissue Res; 2018 Dec; 374(3):607-617. PubMed ID: 30159756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prior increase in metallothionein levels is required to prevent doxorubicin cardiotoxicity.
    Sun X; Kang YJ
    Exp Biol Med (Maywood); 2002 Sep; 227(8):652-7. PubMed ID: 12192109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
    Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
    Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin attenuates CHIP-guarded HSF1 nuclear translocation and protein stability to trigger IGF-IIR-dependent cardiomyocyte death.
    Huang CY; Kuo WW; Lo JF; Ho TJ; Pai PY; Chiang SF; Chen PY; Tsai FJ; Tsai CH; Huang CY
    Cell Death Dis; 2016 Nov; 7(11):e2455. PubMed ID: 27809308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Chaudhari U; Ellis JK; Wagh V; Nemade H; Hescheler J; Keun HC; Sachinidis A
    Amino Acids; 2017 Dec; 49(12):1955-1963. PubMed ID: 28421296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.
    Wu HY; Kang YJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):515-20. PubMed ID: 9808675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway.
    Danz ED; Skramsted J; Henry N; Bennett JA; Keller RS
    Free Radic Biol Med; 2009 Jun; 46(12):1589-97. PubMed ID: 19303434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity.
    Xi L; Zhu SG; Hobbs DC; Kukreja RC
    J Cell Mol Med; 2011 Nov; 15(11):2512-24. PubMed ID: 21251210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting the expression of peroxiredoxin III in H9c2 cells.
    Liu MH; Lin XL; Yuan C; He J; Tan TP; Wu SJ; Yu S; Chen L; Liu J; Tian W; Chen YD; Fu HY; Li J; Zhang Y
    Mol Med Rep; 2016 Jan; 13(1):367-72. PubMed ID: 26573464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice.
    Guenancia C; Li N; Hachet O; Rigal E; Cottin Y; Dutartre P; Rochette L; Vergely C
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):152-62. PubMed ID: 25711856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity.
    Pizarro M; Troncoso R; Martínez GJ; Chiong M; Castro PF; Lavandero S
    Toxicology; 2016 Aug; 370():41-48. PubMed ID: 27666003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid.
    Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C
    Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
    Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
    Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the Cardiac Maintenance and Survival Factor FGF-16 Gene Is Regulated by Csx/Nkx2.5 and Is an Early Target of Doxorubicin Cardiotoxicity.
    Wang J; Jin Y; Cattini PA
    DNA Cell Biol; 2017 Feb; 36(2):117-126. PubMed ID: 27929351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.